The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/12/240/prepub This work was supported by an unrestricted research grant of AEGON Inc. and by the MAMmary carcinoma MOlecular imaging for diagnostics and THerapeutics (MAMMOTH) project of the Dutch Center for Translational Molecular Medicine.
We herein review SPECT- and PET-based approaches for noninvasive molecular imaging-based diagnostics of acute transplant rejection.
H. Pawelski et al. have reviewed SPECT- and PET-based approaches for noninvasive molecular imaging-based diagnostics of acute transplant rejection.
In less than a decade, QDs have overcome many of the intrinsic limitations of traditional fluorophores and become powerful tools in fields such as molecular biology, cell biology, molecular imaging, and medical diagnostics.
These advantages open up opportunities for revolutionary advances in fluorescent labels for biomedical diagnostics, molecular imaging, and photoelectric field [1 7].
Among different kinds of theranostic agents, gadolinium loaded nanoparticles (GdNPs) are one of the most promising theranostic agents which are very promising in combination of diagnostics (molecular imaging) and therapeutics (molecular therapy) functions in a single platform.
Biomarkers found in ovarian cyst fluid may be used as molecular imaging targets for early diagnostics and prediction of therapy.
It is likely that these strategies will govern the new therapeutic modality for both diagnostics (molecular imaging), therapeutics (targeted, cell-specific delivery), and perhaps also theranostics.
In the era of personalized theranostics (therapeutics and diagnostics), molecular imaging with the specific probe(s) would allow the clinical physicians to select the right patients for the appropriate treatment.
Ultrasound molecular imaging is a powerful diagnostic modality using microbubbles coated with targeting ligands specific for endothelial biomarkers.
